Rockwell Medical (RMTI) Scheduled to Post Quarterly Earnings on Tuesday

Rockwell Medical (NASDAQ:RMTIGet Free Report) is set to issue its quarterly earnings data before the market opens on Tuesday, May 14th. Analysts expect the company to announce earnings of ($0.05) per share for the quarter. Rockwell Medical has set its FY 2024 guidance at EPS.Investors that wish to register for the company’s conference call can do so using this link.

Rockwell Medical (NASDAQ:RMTIGet Free Report) last posted its quarterly earnings results on Thursday, March 21st. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.10. The firm had revenue of $22.09 million for the quarter, compared to analysts’ expectations of $22.09 million. Rockwell Medical had a negative net margin of 10.09% and a negative return on equity of 39.17%. On average, analysts expect Rockwell Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Rockwell Medical Stock Up 1.9 %

NASDAQ:RMTI opened at $1.61 on Tuesday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.38 and a current ratio of 1.73. The stock has a 50-day simple moving average of $1.54 and a 200 day simple moving average of $1.61. Rockwell Medical has a one year low of $1.16 and a one year high of $6.24. The company has a market capitalization of $47.27 million, a price-to-earnings ratio of -4.02 and a beta of 1.21.

Analyst Upgrades and Downgrades

Separately, HC Wainwright lowered their target price on shares of Rockwell Medical from $11.00 to $9.00 and set a “buy” rating for the company in a research note on Monday, March 25th.

Get Our Latest Research Report on Rockwell Medical

About Rockwell Medical

(Get Free Report)

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.

Read More

Earnings History for Rockwell Medical (NASDAQ:RMTI)

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.